Eli Lilly Tokenized Stock (Ondo)

Eli Lilly and Company Overview Eli Lilly and Company, founded in 1876 and headquartered in Indianapolis, Indiana, is a global pharmaceutical company that discovers, develops, and markets medicines to improve human health. Its portfolio covers treatments in key areas, including: Diabetes – Insulin brands like Humalog, Humulin, Basaglar, and Trulicity. Cancer – Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Immunology – Olumiant for rheumatoid arthritis and Taltz for psoriasis and related conditions. Neuroscience – Cymbalta for depression, anxiety, and pain; Emgality for migraines; Zyprexa for schizophrenia and bipolar disorder. Other Therapies – Cialis for erectile dysfunction, Forteo for osteoporosis, and COVID-19 antibodies such as Bamlanivimab and Bebtelovimab. Eli Lilly also partners with leading biotech and pharma companies, including Incyte, Boehringer Ingelheim, AbCellera, Junshi Biosciences, and others, to expand its research and innovation pipeline.